Stockreport

Amarin: Stalking Another Buy Around Fourth-Quarter Report [Seeking Alpha]

Acasti Pharma, Inc. - Class A  (ACST) 
Last acasti pharma, inc. - class a earnings: 2/14 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: acastipharma.com/investors
PDF Summary Amarin's stock has experienced a steady sell-off that is following a clear downtrend line. I am stalking another buy around the Q4/2019 earnings in anticipation [Read more]